EMN
Estudian la prevalencia e incidencia de enfermedades de la motoneurona en Cataluña y Valencia
#EMN
Clinical and demographical characteristics in a cohort of MND patients treated with riluzole. Differences between tablets and oral suspension
Romero-Gangonells E, Virgili-Casas MN, Povedano M and Barceló MA. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2023; 24(5-6):369-382. doi: 10.1080/21678421.2023.2192247 (Impact Factor: 2.800, CLINICAL NEUROLOGY, 121/212 Q2)
Estimation of the prevalence and incidence of motor neuron disease in two Spanish regions: Catalonia and Valencia
Barceló MA, Povedano M, Vázquez-Costa JF, Franquet A, Solans M, Saez M. Scientific Reports 2021; 11:6207; doi:10.1038/s41598-021-85395-z (Impact Factor: 4.379, MULTIDISCIPLINARY SCIENCES, 17/73 Q1)
Evaluation of dysphagia in motor neuron disease. Review of available diagnostic tools and new perspectives
Romero-Gangonells E, Virgili-Casas MN, Dominguez-Rubio R, Povedano M, Pérez-Saborit N, Calvo-Malvar N y Barceló MA. Dysphagia, 2021; 36(4):558-573. doi: 10.1007/s00455-020-10170-7 (Impact Factor: 3.438, OTORHINOLARYNGOLOGY 6/44 Q1).
Survival benefit of multidisciplinary care in amyotrophic lateral sclerosis in Spain: association with noninvasive mechanical ventilation
Paipa AJ, Povedano M, Barceló MA, Domínguez R, Saez M, Turón J, Prats E, Farrero E, Virgili N, Martínez JA, Corbella X. Journal of Multidisciplinary Healthcare 2019; 12:465-470. doi: 10.2147/JMDH.S205313 (Impact Factor: 2.404, HEALTH CARE SCIENCES & SERVICES 73/108 Q3)
Spatial assessment of the association between long-term exposure to environmental factors and the occurrence of amyotrophic lateral sclerosis (ALS) in Catalonia, Spain. A population-based nested case-control study
Povedano M, Saez M, Martínez-Matos JA, Barceló MA. Neuroepidemiology 2018; 51(1-2):33-49. doi: 10.1159/000489664 (Impact Factor: 3.261, PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH, 29/181 Q1)